These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety and economic aspects of continuous mammalian cell culture. Werner RG, Walz F, Noé W, Konrad A. J Biotechnol; 1992 Jan; 22(1-2):51-68. PubMed ID: 1367818 [Abstract] [Full Text] [Related]
3. An FDA perspective of manufacturing changes for products in human use. Durfor CN, Scribner CL. Ann N Y Acad Sci; 1992 Oct 13; 665():356-63. PubMed ID: 1416614 [No Abstract] [Full Text] [Related]
4. Large-scale mammalian cell culture. Reiter M, Blüml G. Curr Opin Biotechnol; 1994 Feb 13; 5(2):175-9. PubMed ID: 7764796 [Abstract] [Full Text] [Related]
5. Industrialization of mAb production technology: the bioprocessing industry at a crossroads. Kelley B. MAbs; 2009 Feb 13; 1(5):443-52. PubMed ID: 20065641 [Abstract] [Full Text] [Related]
17. The role of bioreactors in tissue engineering. Martin I, Wendt D, Heberer M. Trends Biotechnol; 2004 Feb 13; 22(2):80-6. PubMed ID: 14757042 [Abstract] [Full Text] [Related]
18. Technological progresses in monoclonal antibody production systems. Rodrigues ME, Costa AR, Henriques M, Azeredo J, Oliveira R. Biotechnol Prog; 2010 Feb 13; 26(2):332-51. PubMed ID: 20043321 [Abstract] [Full Text] [Related]
20. The Super-Spinner: a low cost animal cell culture bioreactor for the CO2 incubator. Heidemann R, Riese U, Lütkemeyer D, Büntemeyer H, Lehmann J. Cytotechnology; 1994 Feb 13; 14(1):1-9. PubMed ID: 7765107 [Abstract] [Full Text] [Related] Page: [Next] [New Search]